Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Altius Minerals to Expand Portfolio with C$520 Million Lithium Royalty Deal December 25, 2025 AI Market Forecast: Top Trends for AI in 2026 December 24, 2025 Kinetiko Commences Trading on North American OTC Market December 23, 2025